Gold, D P <br/><br/>
Results of a phase I clinical trial of a T-cell receptor vaccine in patients with multiple sclerosis. II. Comparative analysis of TCR utilization in CSF T-cell populations before and after vaccination with a TCRV beta 6 CDR2 peptide.  [electronic resource] 

 -  Journal of neuroimmunology  Jun 1997 
 - 29-38 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0165-5728 
<br/><br/><label>Standard No.: </label>10.1016/s0165-5728(97)00029-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amino Acid Sequence<br/>Female<br/>Humans<br/>Middle Aged<br/>Molecular Sequence Data<br/>Multiple Sclerosis--cerebrospinal fluid<br/>Receptors, Antigen, T-Cell, alpha-beta--analysis<br/>T-Lymphocytes--immunology<br/>Vaccination